AstraZeneca expects only limited impact from potential U.S. tariffs on pharmaceutical imports, the drugmaker said on Tuesday, ...

The chief executive of AstraZeneca said on Tuesday that the drugmaker will maintain its 2025 sales guidance even if the U.S.

AstraZeneca may face a fine of up to $8 million in China over suspected unpaid taxes related to the import of its breast ...

The drugmaker posted increased core earnings per share and sales for the first quarter, but also said it could face a fine of ...

AstraZeneca CEO Pascal Soriot is not overly concerned about the threat of tariffs by the Trump administration on ...

British pharmaceutical giant AstraZeneca announced Tuesday that it has begun moving some of its European production to the ...

It’s an incredibly exciting time for AstraZeneca in Canada,” says Gaby Bourbara, President, AstraZeneca Canada. “Since 2023, we have invested $4.3 billion in Canada’s l ...

Following the recent discontinuations of assets in Alzheimer’s and migraine, AstraZeneca is stepping away from neuro ...

The Anglo-Swedish pharmaceutical group on Tuesday reported revenue of $13.6bn in the first three months of the year, up 10 ...

AstraZeneca has come up short in another phase 3 trial of the AKT inhibitor Truqap, raising more questions about the ...

The drug maker said it is ‘firmly committed to investing and growing in the US’ amid potential import tariffs on the ...

AstraZeneca has announced the discontinuation of the CAPItello-280 Phase III trial evaluating the efficacy and safety of ...